Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma

BACKGROUND: In the clinic, how to stratify renal cell carcinoma (RCC) patients with different risks and to accurately predict their prognostic outcome remains a crucial issue. In this study, we assessed the expression and prognostic value of gankyrin in RCC patients. METHODS: The expression of ganky...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EBioMedicine
Autors principals: Wang, Chao, Li, Yan, Chu, Chuan-min, Zhang, Xiang-min, Ma, Jie, Huang, Hai, Wang, Yu-ning, Hong, Tian-yu, Zhang, Jing, Pan, Xiu-wu, Zheng, Jing-cun, Jiang, Ning, Hu, Chuan-yi, Ma, Xiaojing, Sun, Ying-hao, Cui, Xin-gang
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Research paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354735/
https://ncbi.nlm.nih.gov/pubmed/30558998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.12.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars